ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹5.23 Cr | ₹52 Cr | ₹96 Cr | ₹269 Cr | ₹-90 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ASTRAZENECA PHARMA INDIA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹5.23 Cr |
Mar2023 | ₹52 Cr |
Mar2022 | ₹96 Cr |
Mar2021 | ₹269 Cr |
Mar2020 | ₹-90 Cr |
How is Net Cash Inflow / Outflow of ASTRAZENECA PHARMA INDIA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹5.23 Cr | -89.93 | |
Mar2023 | ₹52 Cr | -45.96 | |
Mar2022 | ₹96 Cr | -64.26 | |
Mar2021 | ₹269 Cr | Positive | |
Mar2020 | ₹-90 Cr | - |
Compare Net Cash Inflow / Outflow of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹15,938.6 Cr | -1.9% | -1.9% | 19.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | -1.9% |
-1.9% |
19.3% |
SENSEX | -0.7% |
-1.6% |
11.1% |
You may also like the below Video Courses